Topics

Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors

16:05 EDT 30 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the b...

Other Sources for this Article

Deborah Rathjen
deborah@bioasis.us
+1 203 533 7082

Christina Tartaglia
Stern Investor Relations
christina@sternir.com
+1 212 362 1200

NEXT ARTICLE

More From BioPortfolio on "Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors"

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...